📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-018-0115-6

PubMed Identifier: 30013198

Publication URI: http://europepmc.org/abstract/MED/30013198

Type: Journal Article/Review

Volume: 24

Parent Publication: Nature medicine

Issue: 8

ISSN: 1078-8956